Creative Medical Technology Holdings, Inc. Adjustments to Additional Paid in Capital, Other
Creative Medical Technology Holdings, Inc. (CELZ) reported Adjustments to Additional Paid in Capital, Other of $490.44 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2020-08-14
- Creative Medical Technology Holdings, Inc. adjustments to additional paid in capital, other for the quarter ending 2020-06-30 was $490.44K, a 13.17% decline year-over-year.
- Creative Medical Technology Holdings, Inc. adjustments to additional paid in capital, other for the quarter ending 2020-03-31 was $751.22K, a 26.22% decline year-over-year.
- Creative Medical Technology Holdings, Inc. adjustments to additional paid in capital, other for the quarter ending 2019-12-31 was $290.25K, a 77.50% decline year-over-year.
- Creative Medical Technology Holdings, Inc. adjustments to additional paid in capital, other for the quarter ending 2019-09-30 was $782.23K, a 83.10% decline year-over-year.
- Creative Medical Technology Holdings, Inc. adjustments to additional paid in capital, other for fiscal 2019 was $2.66M, a 75.28% decline from fiscal 2018.
- Creative Medical Technology Holdings, Inc. adjustments to additional paid in capital, other for fiscal 2018 was $10.74M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2020-06-30 | $490.44K 10-Q · filed 2020-08-14 | $1.24M 10-Q · filed 2020-08-14 | $1.53M derived: sum of 3 quarters · filed 2020-08-14 | $2.31M derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $751.22K 10-Q · filed 2020-05-15 | $1.04M derived: sum of 2 quarters · filed 2020-05-15 | $1.82M derived: sum of 3 quarters · filed 2020-05-15 | $2.39M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-12-31 | $290.25K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $1.07M derived: sum of 2 quarters · filed 2020-04-06 | $1.64M derived: sum of 3 quarters · filed 2020-08-14 | $2.66M 10-K · filed 2020-04-06 |
| 2019-09-30 | $782.23K 10-Q · filed 2019-11-14 | $1.35M derived: sum of 2 quarters · filed 2020-08-14 | $2.37M 10-Q · filed 2019-11-14 | $3.66M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-06-30 | $564.82K 10-Q · filed 2020-08-14 | $1.58M 10-Q · filed 2020-08-14 | $2.87M derived: sum of 3 quarters · filed 2020-08-14 | $7.50M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $1.02M 10-Q · filed 2020-05-15 | $2.31M derived: sum of 2 quarters · filed 2020-05-15 | $6.94M derived: sum of 3 quarters · filed 2020-05-15 | $10.09M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $5.92M derived: sum of 2 quarters · filed 2020-04-06 | $9.07M derived: sum of 3 quarters · filed 2020-04-06 | $10.74M 10-K · filed 2020-04-06 |
| 2018-09-30 | $4.63M 10-Q · filed 2019-11-14 | $7.78M derived: sum of 2 quarters · filed 2019-11-14 | $9.45M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $3.15M 10-Q · filed 2019-08-13 | $4.82M 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $1.67M 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |